Manville Asbestos Trust Claims (Johns-Manville)

If you or someone in your family worked around Johns-Manville asbestos products and later developed mesothelioma or another asbestos disease, the trust that pays those claims is the oldest one there is — the trust that invented the model every other asbestos trust follows.

Johns-Manville was the largest asbestos company in America, and for most of the twentieth century its products were everywhere heat and fire had to be managed. When the weight of the lawsuits drove it into Chapter 11 in 1982, no law existed for what came next, so the court and the parties built it: a trust that would take over every asbestos claim, present and future, and pay them in the company's place. The Manville Personal Injury Settlement Trust was consummated in 1988, and Congress later wrote its design into the Bankruptcy Code as Section 524(g), the law behind every asbestos trust on this site. Nearly four decades on, the Manville trust has paid more than $5.3 billion across more than a million claims, holds over half a billion dollars, and is still open and paying.

Here is what makes this trust unlike almost any other: you don't have to name a specific Manville product or job site. Johns-Manville mined and sold so much of the nation's asbestos that the trust presumes its products were part of an asbestos-exposed workplace. If you have an asbestos-related disease and your exposure meets the trust's requirements before the end of 1982, the trust pays — no product identification required. What your claim needs is your diagnosis and your work history, and reconstructing that history is our job, not yours. If you can tell us where you worked and when, we have a place to start.

What the Manville trust pays, by disease

Claim values before the trust's pro rata share is applied.

Scheduled is the amount the trust offers when a claim meets the preset criteria for its disease level. Maximum is the ceiling reachable through individual evaluation or arbitration. Lung cancer 1 (Level VI) has no scheduled value — every claim at that level is individually evaluated, with awards anticipated to average about $40,000 and capped at $50,000. Your actual payment is the claim value times the trust's pro rata share, currently 5.6%, so a mesothelioma claim at the $350,000 scheduled value pays about $19,600, and an individually evaluated claim at the $750,000 maximum pays about $42,000. The one exception is Level I: its $600 cash discount payment is paid in full, with no pro rata reduction — a small, fast, certain payment for claimants who want one. Manville uses the term "pro rata share" for what other trusts call the payment percentage; they're the same idea.

Read these as one trust's share, not your whole recovery. Johns-Manville's products were so widespread that the same job sites that exposed people to Manville asbestos almost always exposed them to other companies' products too, each with its own trust or lawsuit. The claims run in parallel without canceling each other out, so the number that matters for your family is the total across all of them, and that's the case we build. Learn more about how asbestos trust claims work.

How Johns-Manville exposed workers to asbestos

Johns-Manville wasn't one asbestos product; it was the asbestos industry's flagship. The company mined the fiber, milled it, and built it into product lines that reached nearly every trade that worked with heat, steam, or construction: high-temperature pipe covering and block insulation, insulating cements, asbestos-cement pipe and sheet (Transite), roofing felts and shingles, textiles, packings, and boards. Installing those products shed fiber when they were sawed, cut, mixed, and fitted, and tearing out the old material shed far more.

That reach is the reason for the trust's most claimant-friendly rule: it does not require you to identify a specific Manville product or job site. Because the company mined and sold so much of the asbestos in American workplaces, the trust presumes its products were involved wherever asbestos exposure occurred. The product history above explains the presumption; you don't have to prove it item by item.

That reach is also why a Manville claim spans so many trades: insulators and pipefitters handling the insulation lines, laborers cutting Transite pipe, roofers working the felts, and the electricians and other trades who simply shared the buildings where that work happened. And because Manville also sold raw fiber and components to other manufacturers, the same career that supports a Manville claim nearly always points to other companies' trusts as well.

The bankruptcy that invented the asbestos trust

When Johns-Manville filed for Chapter 11 in 1982, it was the largest company ever to seek bankruptcy protection in the United States to that point, and it did so for one reason: asbestos lawsuits it could not pay. Nothing in the Bankruptcy Code then addressed what to do about the people who hadn't gotten sick yet — the future claimants whose diseases were still decades from surfacing. The solution the case produced became the template for everything that followed: a dedicated trust that takes over the company's asbestos liability and pays every claim, present and future, in the company's place.

The Manville Personal Injury Settlement Trust was consummated on November 28, 1988, funded with cash, Manville securities, and insurance settlement proceeds. When Congress amended the Bankruptcy Code in 1994 to create Section 524(g) (the provision under which every later asbestos trust was formed) it was codifying the Manville design. Every trust on this site is, structurally, a descendant of this one.

The trust's early years taught the hard lesson the pro rata system now embodies. Claims arrived in numbers far beyond projections, the courts stayed payments from 1990 to 1995 while a class action restructured the trust, and the settlement that emerged — the TDP, implemented in 1995 — put every claimant on a pro rata share of a limited fund. The courts formally found the trust to be a "limited fund": there is a substantial probability its assets cannot pay all present and future claims in full. That finding is why every claimant receives a percentage, and it is the intellectual ancestor of the payment percentage at every other trust.

Inside the decision to file

Manville's own papers show how it got there. Its lawyers kept a chronology of the asbestos litigation from 1968 to 1982 that sets what the board was told beside what the company told investors. From the first public disclosure in 1974, when it faced 29 suits, through its filing for 1977, J-M's annual reports to the SEC said the lawsuits would have no material adverse effect on the company. By then it faced 623.

In July 1981 the company's lawyers showed the board a projection of 32,500 plaintiffs and nearly $1.5 billion in costs through 1991. In August 1982 a special committee of the board, told by the company's accounting adviser that a reserve for the asbestos claims was now required, recommended filing for Chapter 11 at once. In the affidavit filed with the petitions on August 26, 1982, Manville estimated the cost of the litigation at "anywhere between $2 billion to many times that amount over the next twenty years." That estimate of claims still to come is the problem the trust was built to solve.

What the Manville trust pays, and how the pro rata share works

The trust pays set scheduled values by disease, with mesothelioma at the top, and the full breakdown is in the table near the top of this page. What's distinctive is the machinery around those values.

Claims process in a FIFO queue. Your place in line is set by the date the trust receives an acceptable proof of claim (or the date you filed suit, if earlier). When your claim is reached, the trust categorizes it against the criteria for the eight disease levels and, if it qualifies, mails an offer at the scheduled value. Accept and return the release, and payment follows within 30 days. Offers stay open 360 days before a claim is deactivated, and a claim can be deferred up to three years without losing its place or its filing date.

Individual evaluation can reach higher — with a real caution. Any claimant can reject the scheduled offer and elect individual evaluation under the trust's Claims Resolution Procedures factors: age, dependents, special damages, jurisdiction, the strength of the exposure record. Individual evaluation can reach the maximum value — $750,000 for mesothelioma — but the TDP is explicit that the trust won't exceed the scheduled value unless a higher number is clearly justified, and a claimant who elects it cannot fall back on the original scheduled offer if the evaluation comes in lower. Choosing the track is a judgment call built on the strength of your evidence, and it's one we make case by case.

Arbitration, and even the courtroom, stay open. Disputes go to arbitration, and a claimant who rejects a non-binding arbitration award retains the right to a trial against the trust, which is a path almost no other asbestos trust preserves. Judgments are payable at the pro rata share and capped at the maximum value from the trust's Pool A; amounts above that fall to Pool B, which the TDP itself says may never be funded. Extraordinary Claims — where Manville was essentially the whole of a claimant's exposure, or special damages are exceptionally large — can be valued above the maximum.

Whichever path, the trust pays its pro rata share: currently 5.6 cents on each dollar of a claim's value. The reasoning is the one this trust taught the entire system: a limited fund shared across everyone harmed, including the families who won't be diagnosed until the 2040s. Two features soften it. Level I's $600 cash discount payment is exempt and paid in full. And the TDP caps attorneys' fees on trust claims at the lower of the fee contract or 25%, measured against actual payments — a claimant protection written into the trust's own rules, and a fair one, because the trust's presumption-based process eliminates much of the work normally required to get a claim paid.

The pro rata share has moved in both directions

Manville's percentage history is the longest of any trust, and the trust's quarterly reports document it fully:

When the share rises, claimants previously paid at a lower share have received catch-up payments — it happened in 2008, in 2021, and again in 2026 — though the TDP cautions that equalization above the original 10% is increasingly unlikely. The share is reviewed against the trust's projected assets and liabilities at least every three years, so we confirm the current figure against the trust's notices when your claim is filed.

Is the Manville trust still able to pay?

Yes — and this trust proves it in public four times a year. Unlike nearly every other asbestos trust, which reports annually, Manville files certified financial statements with the bankruptcy court every quarter. From its most recent filing, for the quarter ending March 31, 2026:

• About $539 million for claimants. Net claimants' equity stood at $539.3 million on March 31, 2026, after ending 2025 at $563.3 million — a fund that actually grew by about $6.5 million over 2025 before first-quarter market losses pulled it down.
• About $13 million paid in a single quarter. The trust paid $13.0 million in claims in the first quarter of 2026 and accepted 3,488 settled claims in that quarter alone.
• More than $5.3 billion paid since 1988. Across 1,036,966 settled claims — over a million of them — the trust has put $5.33 billion into claimants' hands, against liquidated claim values exceeding $55 billion, which is the limited-fund arithmetic made visible.

None of that means the money is unlimited. The limited-fund finding is the founding fact of this trust — but the fund is open, transparent to an unusual degree, and paying steadily, and a claim filed today is paid at the current 5.6% share.

Who qualifies for a Manville trust claim

For mesothelioma, the trust's criteria are among the most lenient anywhere: a diagnosis, plus credible evidence of exposure to Manville asbestos products before December 31, 1982. There is no minimum duration and no heavy-dose threshold for mesothelioma. The trust recognizes that mesothelioma can follow from limited exposure. All claims require a ten-year latency between first exposure and diagnosis, which mesothelioma's decades-long latency satisfies in practice.

The other disease levels add duration requirements — though even here, the trust does not ask you to tie the exposure to a named Manville product or site. Levels II through V and VII require six months of occupational asbestos exposure before the end of 1982, plus either five years of cumulative occupational exposure (Level II) or the trust's Significant Occupational Exposure standard.

SOE under the TDP means five cumulative years in which the claimant, on a regular basis: (i) handled raw asbestos fibers; (ii) fabricated asbestos-containing products with exposure to raw fibers in the process; (iii) altered, repaired, or otherwise worked with asbestos-containing products with exposure to the fibers; or (iv) was employed in an industry and occupation working within 10 to 20 feet of workers doing any of those things. “Regular basis” means every workday, for a substantial part of the workday. That fourth clause matters most in practice: a tradesman who spent years working within twenty feet of insulation crews can meet SOE without ever touching the material himself. None of this applies to mesothelioma, which requires no SOE and no minimum duration.

Family members can qualify too. Take-home claims are individually reviewed: the household member's exposure must occur in the same time frame as the worker's own pre-1983 Manville exposure, and the worker's history must itself have met the trust's requirements. Learn more about take-home or secondary asbestos exposure.

The trust's own filing window. In addition to any state statute of limitations, the TDP allows claims to be filed within three years of diagnosis or asbestos-related death. Deadlines stack and interact, and some are shorter than others, so the safe move is a call soon after diagnosis rather than a guess.

How a Manville claim gets filed

A Manville claim is a proof of claim submitted to the trust, processed by the Claims Resolution Management Corporation (CRMC) — the trust's wholly owned claims processor, which the trust started in 1999 and which today also processes claims for other trusts. The claim is ordered FIFO, categorized against the disease criteria, and paid on the trust's offer-and-release mechanics described above. For a living mesothelioma claimant, Exigent Health status moves the claim to the front.

What the claim needs is proof of two things: the diagnosis, and an exposure history that meets the trust's requirements for your disease level — by work history, affidavit, coworker accounts, or other credible evidence. It does not need to name a Manville product or match a job site to any list, because the trust presumes its asbestos was involved. Assembling the history is our job. The fuller mechanics of trust claims generally are in our guide to how asbestos trust claims work.

A Manville claim is rarely the only one

Here's the part that changes the math for most families: because Johns-Manville was the biggest name in a crowded industry, the sites where its products were installed were full of other makers' asbestos too — the insulation, cement, gaskets, and refractories whose companies left their own trusts. The same work history that grounds a Manville claim usually grounds several others, and they pay independently. On its own, a Manville mesothelioma claim at today's 5.6% share is a five-figure payment; built alongside every other trust and lawsuit the history supports, it's part of something much larger. We walk through a worked example, several trusts totaled across one career, in our guide to mesothelioma trust settlement values.